| Thu, Jul 9, 2009 | | • | BenchmarkJournal.com Free Analyst Review for THQI, CTCM, JOSB, ISIS, CETV and BEAT
Marketwire (Thu 8:23am)
| | Tue, Jun 30, 2009 | | • | 5 Stocks Approaching Greatness
at Motley Fool (Tue, Jun 30)
| | Wed, Jun 24, 2009 | | • | Lack Of VC Funding Has Biotechs Ailing
Investor's Business Daily (Wed, Jun 24)
| | Tue, Jun 23, 2009 | | • | Dream Stocks for Biotech Investors
at Motley Fool (Tue, Jun 23)
| | Thu, Jun 11, 2009 | | • | Isis Pharmaceuticals to Present at Jefferies' 3rd Annual Healthcare Conference
PR Newswire (Thu, Jun 11)
| | Tue, Jun 9, 2009 | | • | Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions
PR Newswire (Tue, Jun 9)
| | Mon, Jun 8, 2009 | | • | Your First Move For Tuesday June 9th
at CNBC (Mon, Jun 8)
| | Fri, Jun 5, 2009 | | • | Isis Pharmaceuticals to Present at Needham's 8th Annual Life Sciences Conference
PR Newswire (Fri, Jun 5)
| | Thu, Jun 4, 2009 | | • | ISIS PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financi
EDGAR Online (Thu, Jun 4)
| | • | Isis Pharmaceuticals to Present at Goldman Sachs' 30th Annual Global Healthcare Conference
PR Newswire (Thu, Jun 4)
| | Mon, Jun 1, 2009 | | • | Webcast Alert: Isis Pharmaceuticals To Provide General Corporate Update in Conjunction with 2009 Annual Meeting of Stockholders
PR Newswire (Mon, Jun 1)
| | • | Isis Highlights New Clinical Data on Anti-Cancer Antisense Drugs Featured at ASCO
PR Newswire (Mon, Jun 1)
| | Thu, May 21, 2009 | | • | Jury Still Out On Isis Cholesterol Drug
at Forbes.com (Thu, May 21)
| | • | FDA, Clinical Trial Updates: Heart Stents, Cholesterol in the News
at Seeking Alpha (Thu, May 21)
| | • | Isis, Genzyme May Have a Winning Drug
at Seeking Alpha (Thu, May 21)
| | Wed, May 20, 2009 | | • | ISIS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Wed, May 20)
| | • | Genzyme and Isis say cholesterol drug met goal
AP (Wed, May 20)
| | • | Genzyme and Isis Announce that Mipomersen Phase 3 Study in Patients with Homozygous Familial Hypercholesterolemia Met Primary Endpoint
Business Wire (Wed, May 20)
| | Tue, May 19, 2009 | | • | Webcast Alert: Isis Pharmaceuticals To Provide General Corporate Update in Conjunction with 2009 Annual Meeting of Stockholders
PR Newswire (Tue, May 19)
| | Mon, May 18, 2009 | | • | Lightning Round: ConocoPhillips, Caterpillar, Isis Pharma and More
at CNBC (Mon, May 18)
|
Add ISIS News to My Yahoo!:
 
| |
|
0.06% Nasdaq 0.00%
Headlines
